Status:
COMPLETED
Antiviral Therapy for Influenza A H1N1
Lead Sponsor:
South East Asia Infectious Disease Clinical Research Network
Collaborating Sponsors:
Wellcome Trust
Conditions:
Influenza A Virus Infection
Eligibility:
All Genders
1+ years
Brief Summary
The aims of this study are to characterise the clinical efficacy and virological clearance dynamics of orally administered oseltamivir in patients with influenza caused by novel influenza A(H1N1). Thi...
Detailed Description
Any patient over 1 year of age who presents to a participating institution with confirmed influenza A and who meets the study inclusion/exclusion criteria may be approached for informed consent. Choic...
Eligibility Criteria
Inclusion
- Adults, including pregnant and breast feeding women, and Children aged ≥ 12 months when first seen with an acute febrile respiratory tract illness (ARI) of any severity and influenza A, virologically proven on a respiratory specimen according to hospital procedure, which is suspected to be novel influenza A(H1N1)
- A positive influenza A H1 swine screening reverse transcriptase polymerase chain reaction (RT PCR) or conventional PCR assay on one respiratory specimen : NPA, NP swab, nasal wash, nasal swab and throat swab
- Underlying illnesses including HIV
- Prescribed oseltamivir prior to presentation
Exclusion
- Lack of informed consent
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
181 Patients enrolled
Trial Details
Trial ID
NCT00985582
Start Date
September 1 2009
End Date
September 1 2010
Last Update
May 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Infectious and Tropical Diseases (NIITD), Viet Nam
Hanoi, Vietnam